Skip Navigation


eCAM Advance Access originally published online on October 20, 2005
eCAM 2005 2(4):513-520; doi:10.1093/ecam/neh125
This Article
Right arrow Full Text Freely available
Right arrow Full Text (PDF) Freely available
Right arrowOA All Versions of this Article:
2/4/513    most recent
neh125v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Haddad, P. S.
Right arrow Articles by Boivin, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haddad, P. S.
Right arrow Articles by Boivin, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Author (2005). Published by Oxford University Press. All rights reserved.
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions{at}oxfordjournals.org


Review

Natural Health Products, Modulation of Immune Function and Prevention of Chronic Diseases

Pierre S. Haddad1,2,5,*, Georges A. Azar3, Simon Groom4 and Michel Boivin1,5

1Fondation Lucie et André Chagnon, 2001 McGill College Suite 1000, Montreal, Quebec, Canada, 2Department of Pharmacology, Université de Montréal 2900 Edouard-Montpetit, Montreal, Quebec, Canada, 3Department of Microbiology and Immunology, Université de Montréal 2900 Edouard-Montpetit, Montreal, Quebec, Canada, 4Department of Human Nutrition, Macdonald College, McGill University Ste-Anne-de-Bellevue, Quebec, Canada, and 5Centre Hospitalier de l'Université de Montréal, Hôpital St-Luc 1058 St-Denis, Montreal, Quebec, Canada

The immune system is increasingly found to be involved in the development of several chronic illnesses, for which allopathic medicine has provided limited tools for treatment and especially prevention. In that context, it appears worthwhile to target the immune system in order to modulate the risk of certain chronic illnesses. Meanwhile, natural health products (NHPs) are generating renewed interest, particularly in the prevention and treatment of several chronic diseases. Over 20 scientists from fields related to immune function and NHPs were thus convened to establish the state of knowledge on these subjects and to explore future research directions. This review summarizes the result of discussions held during the symposium. It thus seeks to be thought provoking rather than to comprehensively cover such broad areas of research. Notably, a brief overview of the immune system is presented, including potentially useful targets and strategies to keep it in an equilibrated state, in order to prevent certain disorders. The pertinence and limitations of targeting the immune system to prevent chronic diseases is also discussed. The paper then discusses the usefulness and limitations of current experimental tools available to study the immune modulating effects of NHPs. Finally, a concise review of some of the most studied NHPs showing promising immunomodulatory activity is given, and avenues for future research are described.

Keywords: NK cells – Cytokines – Microparticles – Probiotics – Natraprevention – Vitamins – n-3 fatty acids – Green tea – Echinacea – Ginseng


*For reprints and all correspondence: Pierre S. Haddad, Research Coordinator, Fondation Lucie et André Chagnon, 2001 McGill College Avenue, Montreal, Quebec, Canada H3A 1G1. Tel: +514-380-2001 ext. 1098; Fax: +514-380-8434; E-mail: pierre.haddad{at}umontreal.ca


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Evid Based Complement Alternat MedHome page
G. Klein, J. Kim, K. Himmeldirk, Y. Cao, and X. Chen
Antidiabetes and Anti-obesity Activity of Lagerstroemia speciosa
Evid. Based Complement. Altern. Med., December 1, 2007; 4(4): 401 - 407.
[Abstract] [Full Text] [PDF]


Home page
Evid Based Complement Alternat MedHome page
S. K. Singh, P. K. Rai, D. Jaiswal, and G. Watal
Evidence-based Critical Evaluation of Glycemic Potential of Cynodon dactylon
Evid. Based Complement. Altern. Med., May 17, 2007; (2007) nem044v1.
[Abstract] [Full Text] [PDF]


Home page
Evid Based Complement Alternat MedHome page
J. Kennedy, C.-C. Wang, and C.-H. Wu
Patient Disclosure about Herb and Supplement Use among Adults in the US
Evid. Based Complement. Altern. Med., May 17, 2007; (2007) nem045v1.
[Abstract] [Full Text] [PDF]


Home page
Evid Based Complement Alternat MedHome page
A. Vojdani and J. Erde
Regulatory T Cells, a Potent Immunoregulatory Target for CAM Researchers: Modulating Tumor Immunity, Autoimmunity and Alloreactive Immunity (III)
Evid. Based Complement. Altern. Med., September 1, 2006; 3(3): 309 - 316.
[Abstract] [Full Text] [PDF]


Home page
Evid Based Complement Alternat MedHome page
A. Vojdani and J. Erde
Regulatory T Cells, a Potent Immunoregulatory Target for CAM Researchers: Modulating Allergic and Infectious Disease Pathology (II)
Evid. Based Complement. Altern. Med., June 1, 2006; 3(2): 209 - 215.
[Abstract] [Full Text] [PDF]


Home page
Evid Based Complement Alternat MedHome page
L. S. Adams, N. P. Seeram, M. L. Hardy, C. Carpenter, and D. Heber
Analysis of the Interactions of Botanical Extract Combinations Against the Viability of Prostate Cancer Cell Lines
Evid. Based Complement. Altern. Med., March 1, 2006; 3(1): 117 - 124.
[Abstract] [Full Text] [PDF]


Home page
Evid Based Complement Alternat MedHome page
A. Vojdani and J. Erde
Regulatory T Cells, a Potent Immunoregulatory Target for CAM Researchers: The Ultimate Antagonist (I).
Evid. Based Complement. Altern. Med., March 1, 2006; 3(1): 25 - 30.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.